Sera Prognostics Inc
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel bl… Read more
Sera Prognostics Inc (SERA) - Total Assets
Latest total assets as of September 2025: $108.12 Million USD
Based on the latest financial reports, Sera Prognostics Inc (SERA) holds total assets worth $108.12 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sera Prognostics Inc - Total Assets Trend (2019–2024)
This chart illustrates how Sera Prognostics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sera Prognostics Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Sera Prognostics Inc's total assets of $108.12 Million consist of 65.6% current assets and 34.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.6% |
| Accounts Receivable | $34.00K | 0.1% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.03 Million | 1.4% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Sera Prognostics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sera Prognostics Inc's current assets represent 65.6% of total assets in 2024, a decrease from 92.7% in 2019.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2024, down from 92.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 1.4% of total assets.
Sera Prognostics Inc Competitors by Total Assets
Key competitors of Sera Prognostics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
Sera Prognostics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sera Prognostics Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Sera Prognostics Inc is currently not profitable relative to its asset base.
Sera Prognostics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.89 | 2.11 | 1.22 |
| Quick Ratio | 1.89 | 2.11 | 1.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $20.99 Million | $ 26.93 Million | $ 2.49 Million |
Sera Prognostics Inc - Advanced Valuation Insights
This section examines the relationship between Sera Prognostics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.91 |
| Latest Market Cap to Assets Ratio | 0.71 |
| Asset Growth Rate (YoY) | -24.0% |
| Total Assets | $72.58 Million |
| Market Capitalization | $51.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sera Prognostics Inc's assets below their book value (0.71 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sera Prognostics Inc's assets decreased by 24.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sera Prognostics Inc (2019–2024)
The table below shows the annual total assets of Sera Prognostics Inc from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $72.58 Million | -23.96% |
| 2023-12-31 | $95.44 Million | -17.96% |
| 2022-12-31 | $116.33 Million | -20.88% |
| 2021-12-31 | $147.03 Million | +893.71% |
| 2020-12-31 | $14.80 Million | -36.39% |
| 2019-12-31 | $23.26 Million | -- |